An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality

Marjuki, Henju; Mishin, Vasiliy P.; Chesnokov, Anton P.; De La Cruz, Juan A.; Fry, Alicia M.; Villanueva, Julie; Gubareva, Larisa V.

doi:10.1093/infdis/jiu105

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality

Published Date:

Feb 25 2014

Publisher's site:

http://dx.doi.org/10.1093/infdis/jiu105 New Site Icon

Source:

J Infect Dis. 2014; 210(3):435-440.

[PDF - 816.01 KB]

Details:

Personal Authors:

Marjuki, Henju ; Mishin, Vasiliy P. ; Chesnokov, Anton P. ; De La Cruz, Juan A. ; Fry, Alicia M. ; ... More ▼

Keywords:

[+]

Description:

Human infections caused by avian influenza A virus type subtype H7N9 have been associated with substantial morbidity and mortality. Emergence of virus variants carrying markers of decreased susceptibility to neuraminidase inhibitors was reported. Here we show that DAS181 (Fludase), an antiviral drug with sialidase activity, potently inhibited replication of wild-type influenza A(H7N9) and its oseltamivir-resistant R292K variants in mice. A once-daily administration initiated early after lethal infection hampered body weight loss and completely protected mice from lethality. We observed a time-dependent effect for 24-72-hour delayed DAS181 treatments on morbidity and mortality. The results warrant further investigation of DAS181 for influenza treatment.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Supporting Files:

jiu105.nxml	text/plain
jiu10501.gif	image/gif
jiu10501.jpg	image/jpeg
jiu10502.gif	image/gif
jiu10502.jpg	image/jpeg
license.txt	text/plain
supp_210_3_435__index.html	text/html

No Related Documents.

You May Also Like:

Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus

Personal Author:

Hoopes, Justin D.; Driebe, Elizabeth M.; Kelley, Erin; Engelthaler, David M.; Keim, Paul S.; Perelson, Alan S.; Rong, Libin; Went, Gregory T.; Nguyen, Jack T.;

Published:

Dec 29 2011

Source:

PLoS One. 2011; 6(12).

Description:

Widespread resistance among circulating influenza A strains to at least one of the anti-influenza drugs is a major public health concern. A triple combination antiviral drug (TCAD) regimen comprised of amantadine, oseltamivir, and ribavirin has been ...

File Type:

[PDF - 582.83 KB]
5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication

Personal Author:

Ranjan, Priya; Jayashankar, Lakshmi; Deyde, Varough; Zeng, Hui; Davis, William G; Pearce, Melissa B; Bowzard, John B; Hoelscher, Mary A; Jeisy-Scott, Victoria; Wiens, Mayim E; Gangappa, Shivaprakash; Gubareva, Larisa; García-Sastre, Adolfo; Katz, Jacqueline M; Tumpey, Terrence M; Fujita, Takashi; Sambhara, Suryaprakash;

Published:

May 21 2010

Source:

Virol J. 2010; 7:102.

Description:

Background : Emergence of drug-resistant strains of influenza viruses, including avian H5N1 with pandemic potential, 1918 and 2009 A/H1N1 pandemic viruses to currently used antiviral agents, neuraminidase inhibitors and M2 Ion channel blockers, under...

File Type:

[PDF - 1.03 MB]
Influenza A Strain-Dependent Pathogenesis in Fatal H1N1 and H5N1 Subtype Infections of Mice

Personal Author:

Garigliany, Mutien-Marie; Habyarimana, Adélite; Lambrecht, Bénédicte; Van de Paar, Els; Cornet, Anne; van den Berg, Thierry; Desmecht, Daniel;

Published:

Apr 2010

Source:

Emerg Infect Dis. 16(4):595-603.

Description:

To determine if fatal infections caused by different highly virulent influenza A viruses share the same pathogenesis, we compared 2 different influenza A virus subtypes, H1N1 and H5N1. The subtypes, which had shown no pathogenicity in laboratory mice...

File Type:

[PDF - 738.92 KB]
R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses

Personal Author:

Sleeman, Katrina; Guo, Zhu; Barnes, John; Shaw, Michael; Stevens, James; Gubareva, Larisa V.;

Published:

2013

Source:

Emerg Infect Dis. 19(9):1521-1524.

Description:

Neuraminidase inhibitors are the only licensed antiviral medications available to treat avian influenza A(H7N9) virus infections in humans. According to a neuraminidase inhibition assay, an R292K substitution reduced antiviral efficacy of inhibitors,...

File Type:

[PDF - 562.27 KB]
Deletion of the NSm Virulence Gene of Rift Valley Fever Virus Inhibits Virus Replication in and Dissemination from the Midgut of Aedes aegypti Mosquitoes

Personal Author:

Kading, Rebekah C.; Crabtree, Mary B.; Bird, Brian H.; Nichol, Stuart T.; Erickson, Bobbie Rae; Horiuchi, Kalanthe; Biggerstaff, Brad J.; Miller, Barry R.;

Published:

Feb 13 2014

Source:

PLoS Negl Trop Dis. 2014; 8(2).

Description:

Background : Previously, we investigated the role of the Rift Valley fever virus (RVFV) virulence genes NSs and NSm in mosquitoes and demonstrated that deletion of NSm significantly reduced the infection, dissemination, and transmission rates of RVFV...

File Type:

[PDF - 879.52 KB]